XT
ENTA icon

XTX Topco’s Enanta Pharmaceuticals ENTA Stock Holding History

XTX Topco’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
75,468
+42,257
+127% +$568K 0.01% 1697
2026
Q1 		$419K Buy
+33,211
New +$445K 0.01% 2201
2025
Q2 		– Sell
-19,941
Closed -$110K – 2564
2025
Q1 		$110K Buy
+19,941
New +$123K 0.01% 1851
2024
Q2 		– Sell
-14,282
Closed -$249K – 2025
2024
Q1 		$249K Sell
14,282
-1,689
-11% -$22.3K 0.03% 1004
2023
Q4 		$150K Sell
15,971
-11,251
-41% -$105K 0.03% 1042
2023
Q3 		$304K Buy
27,222
+15,380
+130% +$248K 0.05% 721
2023
Q2 		$253K Buy
+11,842
New +$349K 0.05% 839

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

XTX Topco's ENTA Position: Q2 2026 in Review

XTX Topco increased its Enanta Pharmaceuticals (ENTA) stake by 127% in Q2 2026, buying an estimated $568K and bringing the position to 75,468 shares worth $1.1M. The position accounts for 0.01% of the portfolio, ranked #1697.

XTX Topco first reported a position in ENTA in Q2 2023 and has held it in 7 quarters since. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • XTX Topco held 75,468 shares of Enanta Pharmaceuticals worth $1.1M as of Q2 2026.
  • XTX Topco bought 42,257 Enanta Pharmaceuticals shares in Q2 2026, an estimated $568K.
  • Enanta Pharmaceuticals made up 0.01% of XTX Topco's portfolio in Q2 2026, its #1697 holding.
  • XTX Topco first reported a position in Enanta Pharmaceuticals in Q2 2023 and has held it in 7 quarters since.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.